Medical School: New York College of Osteopathic Medicine
Residency: New York University Langone Medical Center
Board Certification: Anatomic Pathology, Clinical Pathology, Hematopathology, Molecular Genetic Pathology
Fellowship Training: Oncologic Surgical and Molecular Genetic Pathology- MD Anderson Cancer Center
Fellowship Training: Hematopathology – NYU Langone Medical Center
Specialty: Molecular Pathology
Location: Nashville, TN
Dr. Chandra joined PathGroup in 2011 as Associate Medical Director of Molecular Pathology and now currently serves as Chief Medical Officer of Genomic and Clinical Pathology Services at PathGroup. Dr. Chandra holds board certifications in anatomic and clinical pathology, hematopathology and molecular genetic pathology. He completed his AP/CP training and fellowships in hematopathology, oncologic pathology and molecular pathology at NYU Langone Medical Center and the University of Texas-MD Anderson Cancer Center, respectively. While at MD Anderson, he served as Chief Fellow and received numerous awards for his research in acute myeloid leukemia. He has presented numerous abstracts and platform presentations at various pathology meetings and has published peer-reviewed articles and book chapters. Dr. Chandra is a member of the American Society of Clinical Pathology, Association of Molecular Pathology where he also serves in a leadership capacity to the Economic Affairs and Clinical Practice Committees. Dr. Chandra currently serves on the Personalized Healthcare Committee through the College of American Pathologists and is Chair of the Genomic Education workgroup. Dr. Chandra is a medical consultant in molecular pathology and personalized medicine and is considered a national thought leader in Precision Medicine and Cancer Genomics.